Loading...
Loading...
Browse all stories on DeepNewz
VisitWill the Supreme Court uphold the ACA's preventive services mandate by end of 2025?
Yes • 50%
No • 50%
Official ruling published by the U.S. Supreme Court
Supreme Court to Review ACA's No-Cost Coverage for Cancer Screenings, Heart Statins, and HIV Drugs
Jan 10, 2025, 11:26 PM
The U.S. Supreme Court has agreed to review a challenge to the Affordable Care Act's (ACA) requirement for no-cost coverage of certain preventive care services, including cancer screenings, heart statins, and HIV drugs. The case, Braidwood Management, Inc. et al. v. Xavier Becerra, questions the constitutionality of the U.S. Preventive Services Task Force's authority to mandate such coverage. The challenge stems from a ruling by the 5th U.S. Circuit Court of Appeals, which found that the task force's structure violated the Appointments Clause of the U.S. Constitution because its members are not appointed by the president and confirmed by the Senate. The Supreme Court's decision to hear the case could impact the availability of these preventive services, which are currently covered without cost-sharing under the ACA.
View original story
Yes • 50%
No • 50%
Strike down ACA coverage as unconstitutional • 25%
Other • 25%
Remand to lower court for further proceedings • 25%
Uphold ACA coverage as constitutional • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Other outcome • 25%
Rule in favor of South Carolina • 25%
Rule in favor of Planned Parenthood • 25%
Dismiss the case • 25%
No significant change in availability • 25%
Decrease in availability • 25%
Increase in availability • 25%
Other • 25%
Increase in states restricting funding • 25%
Mixed outcomes • 25%
No significant change • 25%
Decrease in states restricting funding • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Full cost-sharing introduced • 25%
Coverage removed • 25%
No change • 25%
Partial coverage introduced • 25%
Most services removed • 25%
All services maintained • 25%
Complete overhaul • 25%
Some services modified • 25%